Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10911446 | Lung Cancer | 2011 | 6 Pages |
Abstract
This retrospective study shows that uPAR(I-III) and uPAR(I) in serum are independent prognostic factors in patients radically operated for NSCLC. Further prospective studies are needed to validate these markers for clinical use.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Charlotte Elberling Almasi, Ib Jarle Christensen, Gunilla Høyer-Hansen, Keld Danø, Helle Pappot, Hendrik Dienemann, Thomas Muley,